bioAffinity Technologies, Inc. (BIAF) stock
BIAFNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as BIAFW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3071% below fair value
$1.93−0.07 (-3.50%)
Close on Nov 17, 2026Market cap $15.64MP/E –Yield –
bioAffinity Technologies EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for bioAffinity Technologies
bioAffinity Technologies has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?